EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RBM15-mediated m6A modification in cancer progression and tumor immunity: molecular mechanisms and therapeutic potential

Chunhong Li, Xiulin Jiang, Yixiao Yuan, Qiang Wang

Frontiers in Cell and Developmental Biology · 01.12.2025 · 13

DOI: 10.3389/fcell.2025.1713615 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 01.12.2025. Verfasst von Chunhong Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Suining Central Hospital, Suining, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RBM15, a key RNA-binding protein involved in m 6 A RNA methylation, plays multifaceted roles in cancer development and tumor immunity. Emerging evidence indicates that RBM15 regulates tumor cell proliferation, migration, invasion, and metabolic reprogramming through modulation of RNA stability, splicing, and translation. Beyond its tumor-intrinsic effects, RBM15 influences the tumor immune microenvironment by affecting immune cell differentiation, activation, and cytokine production, thereby contributing to immune evasion. Dysregulated RBM15 expression has been observed across various cancer types, correlating with poor prognosis and therapy resistance. These findings highlight RBM15 as a promising biomarker for cancer diagnosis and prognosis and suggest its potential as a therapeutic target. Future studies focusing on RBM15-targeted interventions, either alone or in combination with immunotherapy, may provide novel strategies for precision cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

RBM15RNA-binding proteinbiomarkercancer progressionepitranscriptomem6A modificationtherapeutic targettumor immunity

Autor:innen und Institutionen

  • Department of Oncology, Suining Central Hospital, Suining, China.
  • Department of Systems Biology, City of Hope Comprehensive Cancer Center Biomedical Research Center, Monrovia, CA, United States.
  • Department of Gastrointestinal Surgical Unit, Suining Central Hospital, Suining, China.

Zitieren

APA

Li, C., Jiang, X., Yuan, Y., & Wang, Q. (2025). RBM15-mediated m6A modification in cancer progression and tumor immunity: molecular mechanisms and therapeutic potential. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1713615

Vancouver

Li C, Jiang X, Yuan Y, Wang Q. RBM15-mediated m6A modification in cancer progression and tumor immunity: molecular mechanisms and therapeutic potential. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1713615

BibTeX
@article{Li2025,
  author = {Li, Chunhong and Jiang, Xiulin and Yuan, Yixiao and Wang, Qiang},
  title = {RBM15-mediated m6A modification in cancer progression and tumor immunity: molecular mechanisms and therapeutic potential},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1713615}
}
Kostenlos starten →